trial · primary record
QLS4131
Primary Plasma Cell Leukemia
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 15 |
| Primary completion | 2031-12-30 |
| Primary endpoint | Minimal residual disease (MRD) negative rate |
| Registry ID | NCT07903623 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:56.984Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07903623
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Qls4131 · compound